Filing Flows › Apyx Medical (APYX) › Q1 2025
Apyx Medical (APYX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Apyx Medical (APYX) reported revenue of $9.4M for the first quarter 2025 (Q1 2025), -8% from a year earlier and -34% from the quarter before. Operating margin was -32.4%, net loss $4.2M (44.2% of revenue).
Apyx Medical, Q1 2025: revenue $9.4M (-8% year over year), operating margin -32.4%, net loss $4.2M, operating cash flow −$702K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.4M | -34% | -8% |
| Operating profit | −$3.1M | — | — |
| Net earnings | −$4.2M | — | — |
| Operating cash flow | −$702K | — | — |
What changed
Revenue was $9.4M in Q1 2025, down 8% year over year and down 34% from the previous quarter.
Gross margin was 60.1%, up 2.0 points from a year earlier. Operating costs exceeded revenue by $3.1M, an operating margin of -32.4%. Operating expenses fell 31% while revenue fell 8%. The quarter ended with a net loss of $4.2M, narrower than the previous quarter's $4.7M loss. Minority interests bore $22K of it: to shareholders the quarter was a loss of $4.2M.
Operating cash flow was −$702K. Non-cash charges added back $138K of depreciation and amortization and $451K of share-based compensation. Working capital and other items added $2.9M. Capital expenditures of $55K exceeded it, leaving free cash flow of −$757K.
Questions
What was Apyx Medical's revenue in the first quarter 2025?
Apyx Medical (APYX) reported revenue of $9.4M for the first quarter 2025 (Q1 2025), -8% from a year earlier and -34% from the quarter before.
Was Apyx Medical profitable in the first quarter 2025?
Operating loss was $3.1M (-32.4% of revenue) and net loss $4.2M.
Source: Apyx Medical 10-Q on SEC EDGAR.